Registration Frequencies

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: November 3rd, 2018 | n=9095 | updated weekly
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: November 3rd, 2018 | n=9095 | updated weekly
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 883 0
Brodalumab 77 0
Certolizumab 7 0
Efalizumab 35 0
Etanercept 327 29
Golimumab 26 0
Guselkumab 108 0
Infliximab 96 0
Ixekizumab 140 0
Secukinumab 839 0
Ustekinumab 608 0
Apremilast 309 0
Ciclosporin 343 0
Fumaderm 2477 0
Skilarence 383 0
Methotrexate 2143 0
other systemics 295 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: November 3rd, 2018 | n=9095 | updated weekly
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: November 3rd, 2018 | n=9095| updated weekly
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: November 12th, 2018 | n=891 | updated monthly
Fig. 5) Registered PsoBest centers